Global Action to End Smoking Welcomes Nataliia Toropova as Chief Development Officer Français
NEW YORK, June 16, 2025 /CNW/ -- Global Action to End Smoking is pleased to announce the appointment of Nataliia "Natasha" Toropova as its new Chief Development Officer, effective immediately.
"I'm honored to join Global Action, an organization that shares my own values of compassion for those who smoke and my vision of a world without smoking-related deaths," said Toropova.
Natasha will lead Global Action's efforts to expand its philanthropic reach by funding critical research and initiatives that accelerate progress toward ending smoking worldwide. She brings decades of experience in public health, tobacco control, and fundraising including as a Programme Manager for the World Health Organization (WHO) and as an Advocacy Coordinator at Campaign for Tobacco Free Kids in Eastern Europe. In these roles, she not only promoted public health initiatives but also led successful fundraising campaigns to support their missions.
Most recently, Natasha completed her six-year tenure as CEO of Healthy Initiatives, a nonprofit organization committed to strengthening public health by addressing the risk of non-communicable diseases in countries including Ukraine, Eastern Europe, and Central Asia. As a grantee of Global Action, Healthy Initiatives has educated hundreds of health care providers across nine countries in Eastern Europe and Central Asia on the benefits of tobacco harm reduction for people who cannot or will not quit smoking—especially amid the stress of global conflict. The team has also provided critical aid—including CAT tourniquets, ambulances, and mental health support—to the areas most impacted by the ongoing war in Ukraine.
"Natasha brings a bold vision, deep expertise, and an unwavering commitment to public health," said Pam Parizek, Executive Board Chair of Global Action. "She's seen firsthand the positive impact Global Action's support can have to accelerate smoking cessation and is the perfect person to grow our partnerships and lead our efforts to expand our funding for this life-saving work."
Natasha joins Global Action at a pivotal time as the organization reinvigorates its commitment to grantees. Through a recent reorganization, Global Action has ensured its ability to exist until its mission to end smoking is completed, allowing it to honor existing commitments and fund future grants. Natasha's development work will directly support Global Action's grantees, which currently include projects with organizations such as Northwell Health, the National Harm Reduction Coalition and ECLAT, a research-based spinoff of the University of Catania. She will work closely with the executive leadership team to carry out her fundraising and outreach duties.
"Global Action remains steadfast in its commitment to its mission," said Heidi Goldstein, President and Chief Legal Officer of Global Action. "We have now guaranteed that our organization will last to see the end of the global smoking epidemic."
About Global Action to End Smoking
Global Action to End Smoking is an independent U.S. nonprofit 501(c)(3) grantmaking organization whose charitable mission is to end combustible tobacco use, which remains the leading preventable cause of death globally. Historically, Global Action received funding from PMI Global Services, Inc. (PMI). As of September 2023, Global Action and PMI terminated their original funding agreement, and Global Action formally adopted a policy not to seek or accept funding from companies that produce tobacco or non-medicinal nicotine products.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
13 hours ago
- Cision Canada
CooperVision Canada Marks Fifth Year of Raising Awareness About Childhood Myopia and Treatment Options
TORONTO, Aug. 18, 2025 /CNW/ - For the fifth year in a row, CooperVision Canada is investing in educating parents and raising awareness about myopia (aka nearsightedness) in children, emphasizing that it is more than just a blurry vision issue, it is a progressive condition that requires proactive management to help protect long-term eye health and preserve future opportunities for children. MiSight ® 1 day contact lenses from CooperVision can help age-appropriate children with myopia reach their full potential. MiSight ® 1 day is the first and only FDA approved* soft contact lens proven to slow the progression of myopia in children aged 8-12 at the initiation of treatment. 1† Myopia, or nearsightedness, is a common condition where distant objects appear blurry while close-up vision remains clear. It often develops during childhood, typically beginning in the early school years. 2-3 A 2018 study from the University of Waterloo found that 6% of children aged 6-8 had myopia, and this rate jumped to almost 30% for children aged 11-13, 4 highlighting the urgency for early intervention. Research suggests that increased screen time is contributing to the rise in myopia, 5 and studies have shown that spending more time outdoors may prevent or delay the onset of this eye condition. 6 MiSight ® 1 day contact lenses are designed to be part of a proactive myopia management treatment plan, 1† providing freedom from glasses and slowing the worsening of myopia 1† during a child's most critical years of growth. "When children develop myopia at a younger age, their condition tends to worsen more rapidly into their late teens, 7 which increases their risk of sight-threatening eye health conditions later in life, 8" said Teresa Yu, Senior Manager of Marketing, CooperVision Canada. "We remain committed to helping parents understand that myopia is not just a blurry distance vision problem to correct with regular glasses or contact lenses, but a disease that needs to be treated and managed as early as possible. For five years, our direct-to-consumer campaign has focused on educating Canadian families about these critical issues." August is Children's Eye Health and Safety Month, and as part of CooperVision Canada's continual investment and commitment to children's eye health, this back-to-school season they are urging parents to proactively schedule regular eye exams for their children and talk to their eye care professionals about myopia management treatment options. MiSight ® 1 day is a safe, 9 convenient, single-use contact lens that doesn't require cleaning, solutions, or storage so children can start each day with a comfortable, fresh pair of lenses. MiSight ® 1 day is also uniquely backed by a multi-year, peer-reviewed clinical study that demonstrated sustained slowing of myopia progression in children who wore the lenses daily, compared to those wearing single-vision lenses. 1,10-13 The results showed not only significant slowing of eye length growth 1† but also excellent vision correction 1,10± and high satisfaction among young wearers and their parents. 14≠ Over a 3-year period, MiSight ® 1 day contact lenses slowed myopia progression by 59% on average. 1† Parent-approved MiSight ® 1 day contact lenses saw 90% of parents whose children wore the lenses report that their children were extremely happy 14≠ wearing MiSight ® 1 day lenses and strongly preferred them over their glasses. 15 MiSight ® 1 day contact lenses are available through licensed Canadian eye care professionals. To learn more about myopia and MiSight ® 1 day, visit About CooperVision CooperVision, a division of CooperCompanies (Nasdaq: COO), is one of the world's leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges, such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas, and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit About CooperCompanies CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women's health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, Calif., CooperCompanies has a workforce of more than 15,000 with products sold in over 130 countries. For more information, please visit
Cision Canada
14 hours ago
- Cision Canada
No More Juggling a Dozen Apps -- Prevention Now Lives in One Immersive, AI-Powered Experience
Ginkgo Active 4.0 Unlocks Holistic Health Guidance, Making Prevention as Easy as a Daily Check-in VANCOUVER, BC, Aug. 18, 2025 /CNW/ - Ginkgo Active, the world's first Virtual Proactive Health Centre, has launched its most transformative update yet — combining science-based training with interactive habit check-ins to deliver a truly holistic, lifelong prevention experience. In this release, Ginkgo Active goes beyond physical training, integrating the biopsychosocial model into an intelligent, unified platform. Members will now explore their own private health island, where every new assessment unlocks fresh spaces — from the Kitchen for healthy eating, to the Spa for mental wellness, to the Tennis Court for activity and movement literacy. Each space comes with 14-day Healthy Habit Challenges that guide users toward better sleep, nutrition, activity, and social connection. "Prevention doesn't happen with one app or one visit — it's a lifelong journey," said Maggie Deng, Founder & CEO of Ginkgo Health. "This new version brings all the elements of a proactive health plan together in one place, powered by AI, so people can turn knowledge into daily actions without the overwhelm." Why It Matters Full-spectrum prevention: Tackles physical, mental, and social health together — no more scattered apps or siloed advice. AI-powered personalization: Transforms over 570 personal health variables into safe, effective daily guidance. Lifelong engagement: Every new challenge and unlocked space makes healthy living an evolving, rewarding experience. "We've built a fully integrated data and reasoning system that synchronizes traditionally siloed health insights — from sleep and nutrition to activity and social engagement — into a single, adaptive model," said Ruoshi Li, Co-founder & CTO of Ginkgo Health. "Our AI continuously processes vast sets of validated health rules and lifestyle guidelines, then dynamically generates individualized, actionable recommendations at a scale no human expert could match in real time." With this update, Ginkgo Active cements its position as the only platform that delivers precise prevention for decline and chronic conditions in an engaging, scalable, and globally accessible format. Availability: The new Ginkgo Active update is available immediately for all members via App Store and for group enrollments through healthcare payers, employers, and wellness providers. About Ginkgo Active: Ginkgo Active is the world's first Virtual Proactive Health Centre, designed to help people live longer, healthier, more independent lives. Built on evidence-based guidelines and powered by AI, it delivers daily personalized training plans, holistic habit challenges, and continuous progress tracking — all in a single, immersive platform.
Cision Canada
18 hours ago
- Cision Canada
Making health equal by investing in community projects Français
OTTAWA, ON, Aug. 18, 2025 /CNW/ - Today, the Honourable Marjorie Michel, Minister of Health, announced over $3 million for 14 projects to make sure everyone has a fair chance to be healthy. By improving access to food and housing security, job stability, and better health outcomes, these projects, to be completed over the next two years, will help everyone in Canada reach their full health potential and live their healthiest life. Launched in 2021, the Intersectoral Action Fund (ISAF) supports communities to overcome complex public health challenges by strengthening their capacity to collaborate with community members, stakeholders and decision-makers to improve the social conditions that affect health, building the foundation for resilient communities. With the projects announced today, ISAF has now funded 57 projects to advance health equity and strengthen communities to face current and future health challenges across the country. Quotes "By giving everyone a fair chance to live a healthier life, we are not only improving individual well-being, we are also reducing health care costs, boosting productivity and building a stronger economy. These projects demonstrate the importance of working together to address the root causes of health inequities, so all Canadians can have the opportunity to live their healthiest life possible." The Honourable Marjorie Michel Minister of Health Quick Facts Social determinants of health are the social, economic and environmental factors that relate to an individual's place in society and determine individual and population health. This could include gender, race, income, education or employment. These determinants are shaped by the distribution of wealth, power and opportunities within and between populations. Intersectoral action refers to the ways that different groups and sectors of society work together to enhance the health of communities. ISAF helps communities strengthen their capacity for such action and address the social determinants of health and health inequities. Related Products Supporting projects to advance health equity Associated Links Intersectoral Action Fund SOURCE Public Health Agency of Canada
